Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs Quetiapine for Insomnia in Psychiatric Disorders
NCT06062953Phase 3Recruiting
- Start
- Sep 2023
- Primary completion
- Feb 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin, quetiapine in Insomnia. Started Sep 2023; status: recruiting.
02
Drugs
melatoninquetiapine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT06062953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06062953.